查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1930063

全球非处方药市场：市场规模、市场占有率、成长率、行业分析、依类型、应用和地区划分的考察以及未来预测（2025-2034）

Over The Counter Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 140 Pages | 商品交期: 请询问到货日

价格

非处方药市场成长因素

2025年全球非处方药市场规模将达到553.5亿美元，预计2026年将成长至583.2亿美元，最终在2034年达到943.2亿美元，预测期内年复合成长率（CAGR）为6.10%。北美地区在2025年占据市场主导地位，市场占有率达到39.70%，这主要得益于消费者较高的用药意识、完善的零售药房基础设施以及消费者对自我用药的偏好。包括 Johnson & Johnson Services Inc.、Bayer AG、Novartis AG、Sanofi S.A.、Pfizer、GlaxoSmithKline Plc、Boehringer Ingelheim International GmbH、Reckitt Benckiser Group PLC在内的市场主要参与者，致力于产品上市、合作伙伴关係和数位化通路。

非处方药是指无需处方即可购买的药物，用于治疗感冒、身体疼痛、过敏、流感、胃灼热、痤疮和轻微感染等常见疾病。它们透过医院药局、零售药局以及越来越多的电商平台销售。自我用药的兴起、处方药向非处方药的替代以及增强免疫力产品的上市，是推动市场成长的关键因素。例如，Hamdard 于2021年 1月推出了 12 种目的是增强免疫力的非处方药。此外，非处方药还能大幅节省成本，美国消费者每年透过使用非处方药节省约 1,000亿美元。

新冠疫情的影响

新冠疫情对非处方药市场产生了不同的影响。由于人们对增强免疫力和缓解疼痛的意识增强，维生素、矿物质和止痛药的需求增加；而咳嗽感冒药、皮肤护理产品和消化系统药物则因卫生措施和就诊量减少而出现暂时性销量下滑。儘管全球经济动盪，强生服务公司和利洁时集团等公司仍报告其非处方药业务收入成长。

市场趋势

处方药转化为非处方药的：一个关键趋势是将处方药转化为非处方药，提高药物的可及性和可负担性。例如，拜耳公司将一些处方药转化为非处方药，用于自我保健。

自有品牌非处方药及线上销售：各公司纷纷推出自有品牌非处方药，并与电商平台合作。Dr. Reddy's Laboratories Ltd.于2019年9月在美国推出了非处方奥美拉唑锭。由于网路普及率和成本优势，线上销售管道不断扩大。

自有品牌非处方药及线上销售：各公司纷纷推出自有品牌非处方药，并与电商平台合作。于2019年9月在美国推出了非处方奥美拉唑锭。由于网路普及率和成本优势，线上销售管道不断扩大。

市场驱动因素

新产品上市：各大公司正致力于开发创新非处方药。例如，Dr. Reddy's于2020年9月推出了用于缓解过敏症状的盐酸奥洛他定滴眼液。

可近性和价格优势：非处方药在零售店和线上平台的可近性推动了市场成长。处方药转为非处方药的监管审批也进一步促进了其普及。例如，许多处方抗过敏药物在2022年转为非处方药。

市场限制因子

自行用药的风险：误诊、滥用、非处方药的副作用都是限制因素。2020年，美国约有160万12至25岁的年轻人滥用非处方药，包括止咳药和感冒药。药物滥用和传统药物的使用也影响市场成长。

市场区隔

依产品类型划分：

  • 感冒咳嗽药：由于季节性波动以及儿童和老年人的需求，预计到2026年，该细分市场将以 23.99%的市场占有率占据主导地位。
  • 止痛药：由于人口老化和对止痛药需求的不断成长，预计该细分市场将成为第二大市场。
  • 维生素和矿物质：受预防医学意识增强和能量补充剂需求成长的推动，预计该细分市场将成为第三大市场。
  • 其他细分市场包括胃肠道药物、皮肤护理产品、助眠产品和体重管理产品。

依通路划分：

  • 药局和零售药局：受消费者偏好和广泛的零售网路驱动，预计到2026年将占据 45.56%的市场占有率。
  • 医院药局：由于便利性，市场占有率位居第二。
  • 网路药局：由于网路普及率和折扣优惠，成长迅速。

依地区划分：

  • 北美：预计2025年将达到 219.6亿美元，2026年将达到 232.4亿美元。自我用药趋势和完善的基础设施推动了市场发展。预计到2026年，美国非处方药市场规模将达到 215.3亿美元。
  • 欧洲：市场占有率位居第二。预计到2026年，英国和德国的市场占有率将分别达到 18.7亿美元和 44.1亿美元。 非处方药的广泛使用和公众健康素养的提高为此提供了支持。
  • 亚太地区：预计该地区将经历最快的成长。到2026年，日本预计将达到 29.5亿美元，中国达到 42.5亿美元，印度达到 21.9亿美元。自我用药、人口老化以及处方药向非处方药的转变是推动成长的主要因素。
  • 拉丁美洲、中东和非洲：儘管市场规模较小，但由于医疗保健覆盖范围的扩大和非处方药的广泛使用，预计该地区将实现成长。

主要公司

主要公司包括Johnson & Johnson、Bayer AG、Novartis、Sanofi、Pfizer、GlaxoSmithKline、Boehringer Ingelheim、Reckitt Benckiser、Takeda Pharmaceutical、Perrigo。策略性措施包括产品上市、合作和资产剥离。主要进展包括：

  • 2023年6月：MCKESSON推出自有品牌非处方药产品 "Foster & Thrive" 。
  • 2022年7月：RLG Limited与AFT Pharmaceuticals合作，透过天猫国际线上销售非处方药。
  • 2022年6月：Glenmark收购Wockhardt在美国的非处方药ANDA申请。
  • 2022年3月：Perrigo的非处方药 "Nasonex 24小时抗过敏药" 获得美国FDA核准。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会

第4章 主要考察

  • 新产品发布、主要参与者
  • 关键产业趋势：併购、业务合作
  • 新冠疫情对市场的影响

第5章 全球非处方药市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品类型
    • 止痛药
    • 感冒咳嗽药
    • 消化和肠道药物
    • 皮肤保养产品
    • 维生素和矿物质
    • 其他
  • 市场分析、洞察与预测：依销售管道划分
    • 药局和零售药房
    • 医院药房
    • 线上药房
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美非处方药市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国（依产品类型）
    • 加拿大（依产品类型）

第7章 欧洲非处方药市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 德国（依产品类型）
    • 英国（依产品类型）
    • 法国（依产品类型）
    • 西班牙（依产品类型）
    • 义大利（依产品类型）
    • 斯堪的纳维亚半岛（依产品类型）
    • 欧洲其他地区（依产品类型）

第8章 亚太地区非处方药市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 日本（依产品类型）
    • 中国（依产品类型）
    • 印度（依产品类型）
    • 澳洲（依产品类型）
    • 东南亚（依产品类型）
    • 亚太其他地区（依产品类型）

第9章 拉丁美洲非处方药市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 巴西（依产品类型）
    • 墨西哥（依产品类型）
    • 拉丁美洲其他地区（依产品类型）

第10章 中东与非洲非处方药市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • GCC国家（依产品类型）
    • 南亚非洲（依产品类型）
    • 中东和非洲其他地区（依产品类型）

第11章 竞争分析

  • 全球市场占有率分析（2024年）
  • 公司简介
  • Johnson &Johnson Services Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Pfizer
  • GlaxoSmithKline Plc
  • Boehringer Ingelheim International GmbH
  • Reckitt Benckiser Group PLC
  • Takeda Pharmaceutical Company Ltd.
  • Perrigo Company plc
Product Code: FBI105433

Growth Factors of over-the-counter (OTC) drugs Market

The global over-the-counter (OTC) drugs market was valued at USD 55.35 billion in 2025 and is projected to grow to USD 58.32 billion in 2026, ultimately reaching USD 94.32 billion by 2034, reflecting a CAGR of 6.10% during the forecast period. North America dominated the market in 2025 with a 39.70% share, driven by high consumer awareness, strong retail pharmacy infrastructure, and a preference for self-medication. Key players in the market include Johnson & Johnson Services Inc., Bayer AG, Novartis AG, Sanofi S.A., Pfizer, GlaxoSmithKline Plc, Boehringer Ingelheim International GmbH, and Reckitt Benckiser Group PLC, focusing on product launches, partnerships, and digital distribution channels.

OTC drugs are pharmaceutical products available without a prescription and used to manage common health conditions such as colds, body pain, allergies, flu, heartburn, acne, and minor infections. They are sold through hospital pharmacies, retail drug stores, and increasingly via e-commerce platforms. The rising trend of self-medication, the switch of prescription drugs (Rx) to OTC, and the launch of immunity-boosting products are key drivers of market growth. For instance, Hamdard launched 12 OTC drugs for immunity in January 2021. Additionally, OTC products provide significant cost savings, with U.S. consumers saving approximately USD 100 billion annually by using non-prescription medicines.

COVID-19 Impact

The COVID-19 pandemic affected OTC markets differently. Vitamins & minerals and analgesics experienced heightened demand due to increased awareness of immunity and pain relief needs, while cough, cold, skin treatment, and digestive remedies saw a temporary decline in sales due to hygiene measures and reduced patient visits. Companies such as Johnson & Johnson Services Inc. and Reckitt Benckiser Group PLC reported revenue growth in their OTC segments despite global disruptions.

Market Trends

Rx-to-OTC Switch: A major trend is the conversion of prescription drugs to OTC products to increase accessibility and affordability. For example, Bayer AG has shifted some prescriptive drugs to OTC for self-care.

Private-Label OTC Products and Online Sales: Companies are increasingly launching private-label OTC products and partnering with e-commerce platforms. Dr. Reddy's Laboratories Ltd. launched an OTC Omeprazole tablet in the U.S. in September 2019. Online channels are expanding due to internet penetration and cost advantages.

Market Drivers

New Product Launches: Key players are focusing on developing innovative OTC products. For instance, Dr. Reddy's launched Olopatadine Hydrochloride Ophthalmic Solution in September 2020 for allergy relief.

Accessibility and Affordability: The availability of OTC products in retail stores and online platforms enhances market growth. Regulatory approvals for Rx-to-OTC switches further drive adoption. For example, many prescription allergy medicines transitioned to OTC in 2022.

Market Restraints

Self-Medication Risks: Misdiagnosis, misuse, and adverse effects from OTC drugs are restraining factors. In the U.S., around 1.6 million young people (ages 12-25) misused OTC medicines in 2020, including cough and cold products. Drug abuse and traditional medicine use also impact market growth.

Market Segmentation

By Product Type:

  • Cold & Cough Remedies: Dominated in 2026 with 23.99% share due to seasonal variations and prevalence in children and elderly populations.
  • Analgesics: Second-largest segment driven by aging populations and rising pain-relief demand.
  • Vitamins & Minerals: Third-largest, fueled by preventive health awareness and energy supplements.
  • Other segments include digestive & intestinal remedies, skin treatments, and sleeping aids/weight management products.

By Distribution Channel:

  • Drug Stores & Retail Pharmacies: Dominant with 45.56% share in 2026, due to consumer preference and extensive retail networks.
  • Hospital Pharmacies: Second-largest, driven by accessibility.
  • Online Pharmacies: Fast-growing due to internet penetration and discounts.

By Region:

  • North America: Valued at USD 21.96 billion in 2025, projected USD 23.24 billion in 2026; market leadership due to self-medication preference and strong infrastructure. U.S. OTC market expected at USD 21.53 billion in 2026.
  • Europe: Second-largest; UK USD 1.87 billion, Germany USD 4.41 billion in 2026, supported by OTC adoption and health literacy.
  • Asia Pacific: Fastest-growing; Japan USD 2.95 billion, China USD 4.25 billion, India USD 2.19 billion in 2026, driven by self-medication, aging population, and Rx-to-OTC shift.
  • Latin America & Middle East & Africa: Smaller shares, but growth fueled by increasing healthcare access and OTC adoption.

Key Industry Players

Major players include Johnson & Johnson, Bayer AG, Novartis, Sanofi, Pfizer, GlaxoSmithKline, Boehringer Ingelheim, Reckitt Benckiser, Takeda Pharmaceutical, and Perrigo. Strategic initiatives include product launches, partnerships, and divestitures. Notable developments include:

  • June 2023: MCKESSON launched private-brand OTC products, Foster & Thrive.
  • July 2022: RLG Limited partnered with AFT Pharmaceuticals to sell OTC drugs online via Tmall Global.
  • June 2022: Glenmark acquired OTC ANDAs from Wockhardt in the U.S.
  • March 2022: Perrigo received U.S. FDA approval for OTC Nasonex 24HR Allergy.

Conclusion

The global OTC drugs market is projected to grow from USD 55.35 billion in 2025 to USD 94.32 billion by 2034, driven by rising self-medication, Rx-to-OTC switches, product launches, and retail expansion. North America leads the market, while Asia Pacific demonstrates the fastest growth due to increasing health awareness and digital distribution channels. Cold & cough remedies dominate, followed by analgesics and vitamins & minerals. Strategic initiatives by key players, growing e-commerce adoption, and improved affordability will continue to propel market growth, ensuring wider access to safe and effective OTC medications globally.

Segmentation By Product Type

  • Analgesics
  • Cold & Cough Remedies
  • Digestives & Intestinal Remedies
  • Skin Treatment
  • Vitamins & Minerals
  • Others

By Distribution Channel

  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Region

  • North America (By Product Type, By Distribution Channel, and By Country)
    • The U.S. (By Product Type)
    • Canada (By Product Type)
  • Europe (By Product Type, By Distribution Channel, and By Country)
    • The U.K. (By Product Type)
    • Germany (By Product Type)
    • France (By Product Type)
    • Italy (By Product Type)
    • Spain (By Product Type)
    • Rest of Europe (By Product Type)
  • Asia Pacific (By Product Type, By Distribution Channel, and By Country)
    • China (By Product Type)
    • Japan (By Product Type)
    • India (By Product Type)
    • Australia (By Product Type)
    • Southeast Asia (By Product Type)
    • Rest of Asia Pacific (By Product Type)
  • Latin America (By Product Type, By Distribution Channel, and By Country)
    • Brazil (By Product Type)
    • Mexico (By Product Type)
    • Rest of Latin America (By Product Type)
  • Middle East & Africa (By Product Type, By Distribution Channel, and By Country)
    • GCC (By Product Type)
    • South Africa (By Product Type)
    • Rest of Middle East & Africa (By Product Type)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. New Product Launches, Key Players
  • 4.2. Recent Industry Developments - Partnerships, Mergers & Acquisitions
  • 4.3. Impact of Covid-19 on the Market

5. Global Over The Counter Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Analgesics
    • 5.1.2. Cold & Cough Remedies
    • 5.1.3. Digestives & Intestinal Remedies
    • 5.1.4. Skin Treatment
    • 5.1.5. Vitamins & Minerals
    • 5.1.6. Others
  • 5.2. Market Analysis, Insights and Forecast - By Distribution Channels
    • 5.2.1. Drug Stores & Retail Pharmacies
    • 5.2.2. Hospital Pharmacies
    • 5.2.3. Online Pharmacies
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Over The Counter Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Analgesics
    • 6.1.2. Cold & Cough Remedies
    • 6.1.3. Digestives & Intestinal Remedies
    • 6.1.4. Skin Treatment
    • 6.1.5. Vitamins & Minerals
    • 6.1.6. Others
  • 6.2. Market Analysis, Insights and Forecast - By Distribution Channels
    • 6.2.1. Drug Stores & Retail Pharmacies
    • 6.2.2. Hospital Pharmacies
    • 6.2.3. Online Pharmacies
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S. (By Product Type)
    • 6.3.2. Canada (By Product Type)

7. Europe Over The Counter Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Analgesics
    • 7.1.2. Cold & Cough Remedies
    • 7.1.3. Digestives & Intestinal Remedies
    • 7.1.4. Skin Treatment
    • 7.1.5. Vitamins & Minerals
    • 7.1.6. Others
  • 7.2. Market Analysis, Insights and Forecast - By Distribution Channels
    • 7.2.1. Drug Stores & Retail Pharmacies
    • 7.2.2. Hospital Pharmacies
    • 7.2.3. Online Pharmacies
  • 7.3. Market Analysis, Insights and Forecast - By Country
    • 7.3.1. Germany (By Product Type)
    • 7.3.2. U.K. (By Product Type)
    • 7.3.3. France (By Product Type)
    • 7.3.4. Spain (By Product Type)
    • 7.3.5. Italy (By Product Type)
    • 7.3.6. Scandinavia (By Product Type)
    • 7.3.7. Rest of Europe (By Product Type)

8. Asia Pacific Over The Counter Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Analgesics
    • 8.1.2. Cold & Cough Remedies
    • 8.1.3. Digestives & Intestinal Remedies
    • 8.1.4. Skin Treatment
    • 8.1.5. Vitamins & Minerals
    • 8.1.6. Others
  • 8.2. Market Analysis, Insights and Forecast - By Distribution Channels
    • 8.2.1. Drug Stores & Retail Pharmacies
    • 8.2.2. Hospital Pharmacies
    • 8.2.3. Online Pharmacies
  • 8.3. Market Analysis, Insights and Forecast - By Country
    • 8.3.1. Japan (By Product Type)
    • 8.3.2. China (By Product Type)
    • 8.3.3. India (By Product Type)
    • 8.3.4. Australia (By Product Type)
    • 8.3.5. Southeast Asia (By Product Type)
    • 8.3.6. Rest of Asia Pacific (By Product Type)

9. Latin America Over The Counter Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Analgesics
    • 9.1.2. Cold & Cough Remedies
    • 9.1.3. Digestives & Intestinal Remedies
    • 9.1.4. Skin Treatment
    • 9.1.5. Vitamins & Minerals
    • 9.1.6. Others
  • 9.2. Market Analysis, Insights and Forecast - By Distribution Channels
    • 9.2.1. Drug Stores & Retail Pharmacies
    • 9.2.2. Hospital Pharmacies
    • 9.2.3. Online Pharmacies
  • 9.3. Market Analysis, Insights and Forecast - By Country
    • 9.3.1. Brazil (By Product Type)
    • 9.3.2. Mexico (By Product Type)
    • 9.3.3. Rest of Latin America (By Product Type)

10. Middle East & Africa Over The Counter Drugs Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Analgesics
    • 10.1.2. Cold & Cough Remedies
    • 10.1.3. Digestives & Intestinal Remedies
    • 10.1.4. Skin Treatment
    • 10.1.5. Vitamins & Minerals
    • 10.1.6. Others
  • 10.2. Market Analysis, Insights and Forecast - By Distribution Channels
    • 10.2.1. Drug Stores & Retail Pharmacies
    • 10.2.2. Hospital Pharmacies
    • 10.2.3. Online Pharmacies
  • 10.3. Market Analysis, Insights and Forecast - By Country
    • 10.3.1. GCC Countries (By Product Type)
    • 10.3.2. South Africa (By Product Type)
    • 10.3.3. Rest of Middle East & Africa (By Product Type)

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, Financials (based on availability))
    • 11.2.1. Johnson & Johnson Services Inc.
      • 11.2.1.1. Overview,
      • 11.2.1.2. Products,
      • 11.2.1.3. SWOT,
      • 11.2.1.4. Recent Developments,
      • 11.2.1.5. Strategies,
      • 11.2.1.6. Financials (based on availability)
    • 11.2.2. Bayer AG
      • 11.2.2.1. Overview,
      • 11.2.2.2. Products,
      • 11.2.2.3. SWOT,
      • 11.2.2.4. Recent Developments,
      • 11.2.2.5. Strategies,
      • 11.2.2.6. Financials (based on availability)
    • 11.2.3. Novartis AG
      • 11.2.3.1. Overview,
      • 11.2.3.2. Products,
      • 11.2.3.3. SWOT,
      • 11.2.3.4. Recent Developments,
      • 11.2.3.5. Strategies,
      • 11.2.3.6. Financials (based on availability)
    • 11.2.4. Sanofi S.A.
      • 11.2.4.1. Overview,
      • 11.2.4.2. Products,
      • 11.2.4.3. SWOT,
      • 11.2.4.4. Recent Developments,
      • 11.2.4.5. Strategies,
      • 11.2.4.6. Financials (based on availability)
    • 11.2.5. Pfizer
      • 11.2.5.1. Overview,
      • 11.2.5.2. Products,
      • 11.2.5.3. SWOT,
      • 11.2.5.4. Recent Developments,
      • 11.2.5.5. Strategies,
      • 11.2.5.6. Financials (based on availability)
    • 11.2.6. GlaxoSmithKline Plc
      • 11.2.6.1. Overview,
      • 11.2.6.2. Products,
      • 11.2.6.3. SWOT,
      • 11.2.6.4. Recent Developments,
      • 11.2.6.5. Strategies,
      • 11.2.6.6. Financials (based on availability)
    • 11.2.7. Boehringer Ingelheim International GmbH
      • 11.2.7.1. Overview,
      • 11.2.7.2. Products,
      • 11.2.7.3. SWOT,
      • 11.2.7.4. Recent Developments,
      • 11.2.7.5. Strategies,
      • 11.2.7.6. Financials (based on availability)
    • 11.2.8. Reckitt Benckiser Group PLC
      • 11.2.8.1. Overview,
      • 11.2.8.2. Products,
      • 11.2.8.3. SWOT,
      • 11.2.8.4. Recent Developments,
      • 11.2.8.5. Strategies,
      • 11.2.8.6. Financials (based on availability)
    • 11.2.9. Takeda Pharmaceutical Company Ltd.
      • 11.2.9.1. Overview,
      • 11.2.9.2. Products,
      • 11.2.9.3. SWOT,
      • 11.2.9.4. Recent Developments,
      • 11.2.9.5. Strategies,
      • 11.2.9.6. Financials (based on availability)
    • 11.2.10. Perrigo Company plc
      • 11.2.10.1. Overview,
      • 11.2.10.2. Products,
      • 11.2.10.3. SWOT,
      • 11.2.10.4. Recent Developments,
      • 11.2.10.5. Strategies,
      • 11.2.10.6. Financials (based on availability)

List of Tables

  • Table 1: Global Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Over The Counter Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 3: Global Over The Counter Drugs Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 4: North America Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 5: North America Over The Counter Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 6: North America Over The Counter Drugs Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 7: U.S. Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 8: Europe Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 9: Europe Over The Counter Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 10: Europe Over The Counter Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 11: U.K. Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 12: Germany Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 13: France Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 14: Italy Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 15: Spain Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 16: Rest of Europe Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 17: Asia Pacific Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 18: Asia Pacific Over The Counter Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 19: Asia Pacific Over The Counter Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 20: China Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 21: India Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 22: Japan Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 23: Australia Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 24: Southeast Asia Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 25: Rest of Asia Pacific Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 26: Latin America Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 27: Latin America Over The Counter Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 28: Latin America Over The Counter Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Brazil Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 30: Mexico Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 31: Rest of Latin America Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 32: Middle East & Africa Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 33: Middle East & Africa Over The Counter Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 34: Middle East & Africa Over The Counter Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 35: GCC Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 36: South Africa Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 37: Rest of Middle East Over The Counter Drugs Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

List of Figures

  • Figure 1: Global Over The Counter Drugs Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Over The Counter Drugs Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Over The Counter Drugs Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 4: Global Over The Counter Drugs Market Value (USD billion), by Region, 2025 & 2034
  • Figure 5: North America Over The Counter Drugs Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 6: North America Over The Counter Drugs Market Value Share (%), by Product Type, 2025
  • Figure 7: North America Over The Counter Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 8: North America Over The Counter Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 9: North America Over The Counter Drugs Market Value (USD billion), By Country, 2025 & 2034
  • Figure 10: North America Over The Counter Drugs Market Value Share (%), By Country, 2025
  • Figure 11: Europe Over The Counter Drugs Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 12: Europe Over The Counter Drugs Market Value Share (%), by Product Type, 2025
  • Figure 13: Europe Over The Counter Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: Europe Over The Counter Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: Europe Over The Counter Drugs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Over The Counter Drugs Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Over The Counter Drugs Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 18: Asia Pacific Over The Counter Drugs Market Value Share (%), by Product Type, 2025
  • Figure 19: Asia Pacific Over The Counter Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 20: Asia Pacific Over The Counter Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 21: Asia Pacific Over The Counter Drugs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Over The Counter Drugs Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Latin America Over The Counter Drugs Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 24: Latin America Over The Counter Drugs Market Value Share (%), by Product Type, 2025
  • Figure 25: Latin America Over The Counter Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 26: Latin America Over The Counter Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 27: Latin America Over The Counter Drugs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Over The Counter Drugs Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Middle East & Africa Over The Counter Drugs Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 30: Middle East & Africa Over The Counter Drugs Market Value Share (%), by Product Type, 2025
  • Figure 31: Middle East & Africa Over The Counter Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 32: Middle East & Africa Over The Counter Drugs Market Value Share (%), by Distribution Channel, 2025
  • Figure 33: Middle East & Africa Over The Counter Drugs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Over The Counter Drugs Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Global Over The Counter Drugs Market Share (%), By Company, 2025